Eiko Lifesciences standalone net profit declines 57.14% in the March 2022 quarter

23 Apr 2022 , 07:59 AM

Net profit of Eiko Lifesciences declined 57.14% to Rs 0.15 crore in the quarter ended March 2022 as against Rs 0.35 crore during the previous quarter ended March 2021. Sales declined 13.84% to Rs 5.29 crore in the quarter ended March 2022 as against Rs 6.14 crore during the previous quarter ended March 2021.

For the full year,net profit rose 16.39% to Rs 0.71 crore in the year ended March 2022 as against Rs 0.61 crore during the previous year ended March 2021. Sales rose 111.93% to Rs 25.41 crore in the year ended March 2022 as against Rs 11.99 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	5.29	6.14	-14	25.41	11.99	112
OPM %	4.91	6.84	–	5.08	4.34	–
PBDT	0.36	0.50	-28	1.50	0.89	69
PBT	0.20	0.48	-58	0.94	0.83	13
NP	0.15	0.35	-57	0.71	0.61	16

Powered by Capital Market – Live News